Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Fleishaker

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Clinical Neuropharmacology|January 1, 1993
Downregulation of serotonin receptor subtypes by nortriptyline and adinazolam in major depressive disorder: neuroendocrine and platelet markersS M Stahl, R L Hauger, J L Rausch, et al.
Psychopharmacology|June 13, 2001
Pharmacokinetics of reboxetine in healthy volunteers with different ethnic descentsP E Hendershot, J C Fleishaker, K M Lin, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Biotransformation of tirilazad in human: 2. Effect of ketoconazole on tirilazad clearance and oral bioavailabilityJ C Fleishaker, P G Pearson, L C Wienkers, et al.
Clinical Pharmacology and Therapeutics|September 15, 2001
Lack of effect of reboxetine on cardiac repolarizationJ C Fleishaker, S F Francom, B D Herman, et al.
Journal of Clinical Pharmacology|June 1, 1991
Comparison of adinazolam pharmacokinetics and effects in healthy and cirrhotic subjectsP D Kroboth, R A Maxwell, J C Fleishaker, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 26, 2001
Pharmacokinetics of reboxetine in healthy, elderly volunteersJ F Bergmann, J P Laneury, P Duchene, et al.
Journal of Clinical Pharmacology|May 1, 1993
Psychomotor and memory effects of two adinazolam formulations assessed by a computerized neuropsychological test batteryJ C Fleishaker, T A Sisson, J J Sramek, et al.
Clinical Pharmacology and Therapeutics|April 1, 1994
Effect of age and gender on tirilazad pharmacokinetics in humansL K Hulst, J C Fleishaker, G R Peters, et al.
Journal of Clinical Pharmacology|March 12, 1999
Hormonal effects on tirilazad clearance in women: assessment of the role of CYP3AJ C Fleishaker, L K Pearson, P G Pearson, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1988
Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimensJ F Flaherty, L C Rodondi, B J Guglielmo, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Clinical Neuropharmacology|January 1, 1993
Downregulation of serotonin receptor subtypes by nortriptyline and adinazolam in major depressive disorder: neuroendocrine and platelet markersS M Stahl, R L Hauger, J L Rausch, et al.
Psychopharmacology|June 13, 2001
Pharmacokinetics of reboxetine in healthy volunteers with different ethnic descentsP E Hendershot, J C Fleishaker, K M Lin, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Biotransformation of tirilazad in human: 2. Effect of ketoconazole on tirilazad clearance and oral bioavailabilityJ C Fleishaker, P G Pearson, L C Wienkers, et al.
Clinical Pharmacology and Therapeutics|September 15, 2001
Lack of effect of reboxetine on cardiac repolarizationJ C Fleishaker, S F Francom, B D Herman, et al.
Journal of Clinical Pharmacology|June 1, 1991
Comparison of adinazolam pharmacokinetics and effects in healthy and cirrhotic subjectsP D Kroboth, R A Maxwell, J C Fleishaker, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 26, 2001
Pharmacokinetics of reboxetine in healthy, elderly volunteersJ F Bergmann, J P Laneury, P Duchene, et al.
Journal of Clinical Pharmacology|May 1, 1993
Psychomotor and memory effects of two adinazolam formulations assessed by a computerized neuropsychological test batteryJ C Fleishaker, T A Sisson, J J Sramek, et al.
Clinical Pharmacology and Therapeutics|April 1, 1994
Effect of age and gender on tirilazad pharmacokinetics in humansL K Hulst, J C Fleishaker, G R Peters, et al.
Journal of Clinical Pharmacology|March 12, 1999
Hormonal effects on tirilazad clearance in women: assessment of the role of CYP3AJ C Fleishaker, L K Pearson, P G Pearson, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1988
Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimensJ F Flaherty, L C Rodondi, B J Guglielmo, et al.
Pageof 8